维普中文期刊产品整合服务
6篇 您的检索式:作者名="Shuchong"
    题名 作者 年代 出处 被引量
1Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus显示文摘Eric W. Holroyd Sinny Delacroix Katarina Larsen Adriana Harbuzariu Peter J. Psaltis Ling Wang Shuchong Pan Thomas A. White Tyra A. Witt Laurel S. Kleppe Cheryl S. Mueske Debabrata Mukhopadhyay Robert D. Simari 2012Arteriosclerosis, Thrombosis, and Vascular Biology2012,,3:1
2Hepcidin and GDF15 in anemia of multiple myeloma显示文摘Shuchong Mei Huaquan Wang Rong Fu Wen Qu Limin Xing Guojin Wang Jia Song Hong Liu Lijuan Li Xiaoming Wang Yuhong Wu Jin Guan Erbao Ruan Zonghong Shao 2014International Journal of Hematology2014,,3:1
3Characterization of a Resident Population of Adventitial Macrophage Progenitor Cells in Postnatal Vasculature显示文摘Peter J. Psaltis Amrutesh S. Puranik Daniel B. Spoon Colin D. Chue Scott J. Hoffman Tyra A. Witt Sinny Delacroix Laurel S. Kleppe Cheryl S. Mueske Shuchong Pan Rajiv Gulati Robert D. Simari 2014Circulation Research2014,,3:1
4Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces显示文摘Douglas A. Simonetto Hui‐yin Yang Meng Yin Thiago M. de Assuncao Jung Hee Kwon Moira Hilscher Shuchong Pan Liu Yang Yan Bi Arthur Beyder Sheng Cao Robert D. Simari Richard Ehman Patrick S. Kamath Vijay H. Shah 2015Hepatology2015,,2:1
5In vitro apatite formation and its growth kinetics on hydroxyapatite/polyetheretherketione biocomposites显示文摘Yu Shuchong Hariraw K P Kumarr R 2005Biomaterials2005,26,15:1
6Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia显示文摘Loss of TGF-β-mediated growth suppression is a major contributor to the development of cancers,best exemplified by loss-offunction mutations in genes encoding components of the TGF-βsignaling pathway in colorectal and pancreatic cancers.Alternatively,gain-of-function oncogene mutations can also disrupt antiproliferative TGF-βsignaling.However,the molecular mechanisms underlying oncogene-induced modulation of TGF-βsignaling have not been extensively investigated.Here,we show that the oncogenic BCR-ABL1 of chronic myelogenous leukemia(CML)and the cellular ABL1 tyrosine kinases phosphorylate and inactivate Smad4 to block antiproliferative TGF-βsignaling.Mechanistically,phosphorylation of Smad4 at Tyr195,Tyr301,and Tyr322 in the linker region interferes with its binding to the transcription co-activator p300/CBP,thereby blocking the ability of Smad4 to activate the expression of cyclin-dependent kinase(CDK)inhibitors and induce cell cycle arrest.In contrast,the inhibition of BCR-ABL1 kinase with Imatinib prevented Smad4 tyrosine phosphorylation and re-sensitized CML cells to TGF-β-induced antiproliferative and pro-apoptotic responses.Furthermore,expression of phosphorylation-site-mutated Y195F/Y301F/Y322F mutant of Smad4 in Smad4-null CML cells enhanced antiproliferative responses to TGF-β,whereas the phosphorylation-mimicking Y195E/Y301E/Y322E mutant interfered with TGF-βsignaling and enhanced the in vivo growth of CML cells.These findings demonstrate the direct role of BCR-ABL1 tyrosine kinase in suppressing TGF-βsignaling in CML and explain how Imatinib-targeted therapy restored beneficial TGF-βanti-growth responses.Lijing Wang Shuchen Gu Fenfang Chen Yi Yu Jin Cao Xinran Li Chun Gao Yanzhen Chen Shuchong Yuan Xia Liu Jun Qin Bin Zhao Pinglong Xu Tingbo Liang Hongyan Tong Xia Lin Xin-Hua Feng 2023Signal Transduction and Targeted Therapy2023,8,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费